Valuation: Illumina, Inc.

Capitalization 1.91TCr 1.64TCr 1.48TCr 1.42TCr 2.59TCr 1,75100Cr 2.72TCr 18TCr 7.02TCr 84TCr 7.15TCr 7TCr 3,00300Cr P/E ratio 2026 *
26.8x
P/E ratio 2027 * 23.1x
Enterprise value 1.88TCr 1.62TCr 1.47TCr 1.41TCr 2.57TCr 1,73200Cr 2.69TCr 17TCr 6.95TCr 83TCr 7.07TCr 6.92TCr 2,97000Cr EV / Sales 2026 *
4.15x
EV / Sales 2027 * 3.73x
Free-Float
79.72%
Yield 2026 *
-
Yield 2027 * -
1 day-2.82%
1 week-7.32%
Current month-7.32%
1 month+4.09%
3 months-3.37%
6 months+25.97%
Current year-4.99%
1 week 124.06
Extreme 124.06
133.34
1 month 112.65
Extreme 112.65
134.76
Current year 112.65
Extreme 112.65
155.53
1 year 68.7
Extreme 68.7
155.53
3 years 68.7
Extreme 68.7
238.55
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer - 09/08/2023
Director TitleAgeSince
Director/Board Member 71 29/11/2012
Director/Board Member 70 28/01/2016
Director/Board Member 65 28/07/2016
Change 5d. change 1-year change 3-years change Capi.($)
-2.82%-7.32%+43.87%-40.22% 1.91TCr
-3.25%-3.67%-5.59%-8.54% 19TCr
-1.32%-2.65%-5.42%+112.46% 17TCr
-3.22%-7.19%-7.81%-20.29% 14TCr
-2.25%-7.16%-28.02%+51.74% 11TCr
-0.22%-4.11%-22.85%-20.33% 5.23TCr
-2.68%-5.59%+16.08%+3.45% 4.74TCr
-0.96%-1.32%+8.79%+17.60% 3.67TCr
-3.68%-11.87%-14.22%-2.60% 3.38TCr
-2.57%-5.20%-9.18%-18.00% 3.25TCr
Average -2.30%-4.57%-2.44%+7.53% 8.26TCr
Weighted average by Cap. -2.37%-4.06%-7.37%+22.95%

Financials

2026 *2027 *
Net sales 453.59Cr 391.09Cr 353.04Cr 338.75Cr 617.71Cr 42TCr 646.46Cr 4.17TCr 1.67TCr 20TCr 1.7TCr 1.67TCr 71TCr 478.79Cr 412.81Cr 372.65Cr 357.56Cr 652.02Cr 44TCr 682.37Cr 4.41TCr 1.76TCr 21TCr 1.8TCr 1.76TCr 75TCr
Net income 75Cr 65Cr 59Cr 56Cr 102.59Cr 6.92TCr 107.36Cr 693.12Cr 277.68Cr 3.32TCr 282.73Cr 276.7Cr 12TCr 88Cr 75Cr 68Cr 65Cr 119.17Cr 8.04TCr 124.72Cr 805.18Cr 322.57Cr 3.86TCr 328.44Cr 321.43Cr 14TCr
Net Debt -21Cr -18Cr -16Cr -16Cr -28Cr -1.91TCr -30Cr -191.64Cr -77Cr -917.93Cr -78Cr -77Cr -3.28TCr -119.98Cr -103.45Cr -93Cr -90Cr -163.39Cr -11TCr -171Cr -1.1TCr -442.26Cr -5.29TCr -450.3Cr -440.7Cr -19TCr
Logo Illumina, Inc.
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.
Employees
8,625
Date Price Change Volume
06/26/06 124.62 $ -2.82% 14,77,749
05/26/05 128.24 $ -0.57% 13,17,646
04/26/04 128.97 $ -0.46% 13,08,132
03/26/03 129.56 $ -2.51% 14,35,963
02/26/02 132.89 $ -1.17% 22,00,874
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
124.62USD
Average target price
136.05USD
Spread / Average Target
+9.17%

Quarterly revenue - Rate of surprise